fda status bpc 157 2026 Peptide Reclassification 2026: What It Means for Providers Hot-button peptides like BPC-157 and

Independent testing of research peptide products has found significant variability in actual peptide content, including products that contained substantially less active compound than labeled, and products that failed sterility testing

If fatigue arrives with shakiness, sweating, confusion, palpitations, or unusual hunger, people with diabetes should follow their clinicians glucose plan and seek medical guidance

Cagrilintide vs retatrutide Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

A physician at one clinic who voted yes framed it directly: "As a physician, I have to make sure that I'm keeping patients as safe as possible." Pushing these compounds entirely underground does not accomplish that

A "natural" origin of a substance tells you nothing about overall safety at a synthetic dose, by an unphysiological route, in a manufactured form whose purity is not independently verified